Metraipolis › archive › dc_7bdf77409221

CGRP-Targeted Therapy in Vestibular Migraine-How Strong Is the Evidence? — Europe PMC PMID:42396702

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42396702
DOI
10.1111/ene.70688
License (as archived)
solo-consultazione
Archived
2026-10-18T14:16:50.243Z
SHA-256 of the archived text
83c0bd0d0a5f59690d8a98e4c136eef1e1310bdb958a8690d3599e126bbc9f08
Stable URL of this page
https://metraipolis.com/documento/dc_7bdf77409221

How to cite

CGRP-Targeted Therapy in Vestibular Migraine-How Strong Is the Evidence? — Europe PMC PMID:42396702 — Europe PMC (en), https://europepmc.org/article/MED/42396702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bdf77409221 (Metraipolis archive dc_7bdf77409221, sha256 83c0bd0d0a5f59690d8a98e4c136eef1e1310bdb958a8690d3599e126bbc9f08)
BibTeX
@misc{dc7bdf77409221,
  title = {CGRP-Targeted Therapy in Vestibular Migraine-How Strong Is the Evidence? — Europe PMC PMID:42396702},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42396702},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bdf77409221; sha256 83c0bd0d0a5f59690d8a98e4c136eef1e1310bdb958a8690d3599e126bbc9f08},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42396702. Agents can read the archived copy with the MCP tool read_document.